Skip to main content
Figure 7 | Molecular Cancer

Figure 7

From: Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes

Figure 7

Siglec-9 binds to csMUC16 and mediates immune cell-target cell binding. A, Siglec-9 expressing Jurkat cells were stained with CellTracker Blue and MUC16negOVC or MUC16posOVC cells were stained with CellTracker Green. The Jurkat cells and tumor targets were mixed in 1:1 ratio, incubated for 30 min at room temperature and conjugate formation was determined by flow cytometry as described previously [16]. Mean and standard deviation data for percent conjugation obtained from three independent flow cytometry experiments are summarized in the bar chart. B, A direct 96-well plate-based cell adhesion assay was also used to measure binding of MUC16posOVC and Siglec-9 expressing Jurkat cells. Ovarian tumor cells were plated in 96-well plates. Calcein AM labeled Siglec-9pos or Siglec-7pos Jurkat cells were added to the wells. After 25 min incubation wells were washed three times and the amount of fluorescence remaining in the wells was measured. Data shown is mean of six experiments.

Back to article page